Journal of the American Society of Hypertension
Volume 1, Issue 1 , Pages 17-29 , January 2007

Nitric oxide signaling in vascular biology

  • Ka Bian, MD, PhD

      Affiliations

    • The Institute of Molecular Medicine, The University of Texas-Houston Medical School, Houston, Texas, USA
    • The Murad Research Institute for Modernized Chinese Medicine and Shanghai University of Traditional Chinese Medicine, Shanghai, China
    • E-Research Institute of Nitric Oxide and Inflammatory Medicine of Shanghai Universities, Shanghai, China
    • ,
  • Ferid Murad, MD, PhD

      Affiliations

    • The Institute of Molecular Medicine, The University of Texas-Houston Medical School, Houston, Texas, USA
    • The Murad Research Institute for Modernized Chinese Medicine and Shanghai University of Traditional Chinese Medicine, Shanghai, China
    • Corresponding Author InformationCorresponding authors: Ka Bian, MD, PhD, and Ferid Murad, MD, PhD, The Institute of Molecular Medicine, The University of Texas-Houston Medical School, 6431 Fannin, Houston, Texas 77030. Tel: 713-500-2469; fax: 713-500-2447.

Received 17 November 2006 ,Accepted 17 November 2006.

References 

  1. Willerson JT, Kereiakes DJ. Endothelial dysfunction. Circulation. 2003;108:2060–2061
  2. Katsuki S, Arnold W, Mittal C, Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res. 1977;3:23–35
  3. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373–376
  4. Bian K, Davis K, Kuret J, Binder L, Murad F. Nitrotyrosine formation with endotoxin-induced kidney injury detected by immunohistochemistry. Am J Physiol. 1999;277:F33–F40
  5. Ishii N, Patel KP, Lane PH, et al. Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol. 2001;12:1630–1639
  6. Eiserich JP, Hristova M, Cross CE, et al. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature. 1998;391:393–397
  7. Marsh N, Marsh A. A short history of nitroglycerine and nitric oxide in pharmacology and physiology. Clin Exp Pharmacol Physiol. 2000;27:313–319
  8. Ignarro LJ, Lippton H, Edwards JC, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, NO2 ±, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981;218:739–749
  9. Bennett BM, Schroder H, Hayward LD, Waldman SA, Murad F. Effect of in vitro organic nitrate tolerance on relaxation, cyclic GMP accumulation, and guanylate cyclase activation by glyceryl trinitrate and the enantiomers of isoidide dinitrate. Circ Res. 1988;63:693–701
  10. Papapetropoulos A, Go CY, Murad F, Catravas JD. Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells. Br J Pharmacol. 1996;117:147–155
  11. Chen Z, Zhang J, Stamler JS. Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci U S A. 2002;99:8306–8311
  12. Ignarro LJ, Kadowitz PJ, Baricos WH. Evidence that regulation of hepatic guanylate cyclase activity involves interactions between catalytic site-SH groups and both substrate and activator. Arch Biochem Biophys. 1981;208:75–86
  13. Gow AJ, Chen Q, Hess DT, Day BJ, Ischiropoulos H, Stamler JS. Basal and stimulated protein S-nitrosylation in multiple cell types and tissues. J Biol Chem. 2002;277:9637–9640
  14. Al-Sa’doni H, Ferro A. S-nitrosothiols: a class of nitric oxide-donor drugs. Clin Sci (Lond). 2000;98:507–520
  15. Gaston B. Nitric oxide and thiol groups. Biochim Biophys Acta. 1999;1411:323–333
  16. Hogg N. Biological chemistry and clinical potential of S-nitrosothiols. Free Radic Biol Med. 2000;28:1478–1486
  17. Patel RP. Biochemical aspects of the reaction of hemoglobin and NO: implications for Hb-based blood substitutes. Free Radic Biol Med. 2000;28:1518–1525
  18. McMahon TJ, Moon RE, Luschinger BP, et al. Nitric oxide in the human respiratory cycle. Nat Med. 2002;8:711–717
  19. Pawloski JR, Hess DT, Stamler JS. Export by red blood cells of nitric oxide bioactivity. Nature. 2001;409:622–626
  20. Joshi MS, Ferguson TB, Han TH, et al. Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditions. Proc Natl Acad Sci U S A. 2002;99:10341–10346
  21. Jourd’heuil D, Hallen K, Feelisch M, Grisham MB. Dynamic state of S-nitrosothiols in human plasma and whole blood. Free Radic Biol Med. 2000;28:409–417
  22. Jia L, Blantz RC. The effects of S-nitrosocaptopril on renal filtration and blood pressure in rats. Eur J Pharmacol. 1998;354:33–41
  23. Stamler JS, Simon DI, Jaraki O, et al. S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and anti-platelet properties on the enzyme. Proc Natl Acad Sci U S A. 1992;89:8087–8091
  24. Morley D, Keefer LK. Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators. J Cardiovasc Pharmacol. 1993;22(suppl 7):S3–S9
  25. Fitzhugh AL, Keefer LK. Diazeniumdiolates: pro- and antioxidant applications of the “NONOates”. Free Radic Biol Med. 2000;28:1463–1469
  26. Turko IV, Murad F. Protein nitration in cardiovascular diseases. Pharmacol Rev. 2002;54:619–634
  27. Bian K, Murad F. Nitric oxide (NO)—biogeneration, regulation, and relevance to human diseases. Front Biosci. 2003;8:d264–d278
  28. Willerson JT. Systemic and local inflammation in patients with unstable atherosclerotic plaques. Prog Cardiovasc Dis. 2002;44:469–478
  29. Beckmann JS, Ye YZ, Anderson PG, et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler. 1994;375:81–88
  30. Evans P, Kaur H, Mitchinson MJ, Halliwell B. Do human atherosclerotic lesions contain nitrotyrosine?. Biochem Biophys Res Commun. 1996;226:346–351
  31. Morton LW, Puddey IB, Croft KD. Comparison of nitration and oxidation of tyrosine in advanced human carotid plaque proteins. Biochem J. 2003;370:339–344
  32. Sucu N, Unlu A, Tamer L, et al. 3-Nitrotyrosine in atherosclerotic blood vessels. Clin Chem Lab Med. 2003;41:23–25
  33. Luoma JS, Stralin P, Marklund SL, Hiltunen TP, Sarkioja T, Yla-Herttuala S. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol. 1998;18:157–167
  34. Baker CS, Hall RJ, Evans TJ, et al. Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler Thromb Vasc Biol. 1999;19:646–655
  35. Leeuwenburgh C, Hardy MM, Hazen SL, et al. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem. 1997;272:1433–1436
  36. Zou MH, Leist M, Ullrich V. Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries. Am J Pathol. 1999;154:1359–1365
  37. Bar-Shavit R, Sabbah V, Lampugnani MG, et al. An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion. J Cell Biol. 1991;112:335–344
  38. Vadseth C, Souza JM, Thomson L, et al. Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species. J Biol Chem. 2004;279:8226–8820
  39. Murad F. Cellular signaling with nitric oxide and cyclic GMP. Braz J Med Biol Res. 1999;32:1317–1327
  40. Beckman JS. Protein tyrosine nitration and peroxynitrite. Faseb J. 2002;16:1144
  41. Souza JM, Daikhin E, Yudkoff M, Raman CS, Ischiropoulos H. Factors determining the selectivity of protein tyrosine nitration. Arch Biochem Biophys. 1999;371:169–178
  42. Wu W, Chen Y, Hazen SL. Eosinophil peroxidase nitrates protein tyrosyl residues (Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders). J Biol Chem. 1999;274:25933–25944
  43. Sampson JB, Ye Y, Rosen H, Beckman JS. Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide. Arch Biochem Biophys. 1998;356:207–213
  44. Thukkani AK, Albert CJ, Wildsmith KR, et al. Myeloperoxidase-derived reactive chlorinating species from human monocytes target plasmalogens in low density lipoprotein. J Biol Chem. 2003;278:36365–36372
  45. Augusto O, Bonini MG, Amanso AM, Linares E, Santos CC, De Menezes SL. Nitrogen dioxide and carbonate radical anion: two emerging radicals in biology. Free Radic Biol Med. 2002;32:841–859
  46. Dunford HB. One-electron oxidations by peroxidases. Xenobiotica. 1995;25:725–733
  47. Paoli M, Marles-Wright J, Smith A. Structure-function relationships in heme-proteins. DNA Cell Biol. 2002;21:271–280
  48. Nelson MJ, Batt DG, Thompson JS, Wright SW. Reduction of the active-site iron by potent inhibitors of lipoxygenases. J Biol Chem. 1991;266:8225–8229
  49. Poulos TL, Li H, Raman CS. Heme-mediated oxygen activation in biology: cytochrome c oxidase and nitric oxide synthase. Curr Opin Chem Biol. 1999;3:131–137
  50. Ponka P. Cell biology of heme. Am J Med Sci. 1999;318:241–256
  51. Asatryan L, Ziouzenkova O, Duncan R, Sevanian A. Heme and lipid peroxides in hemoglobin-modified low-density lipoprotein mediate cell survival and adaptation to oxidative stress. Blood. 2003;102:1732–1739
  52. Isogai Y, Iizuka T, Shiro Y. The mechanism of electron donation to molecular oxygen by phagocytic cytochrome b558. J Biol Chem. 1995;270:7853–7857
  53. Thomas DD, Espey MG, Vitek MP, Miranda KM, Wink DA. Protein nitration is mediated by heme and free metals through Fenton-type chemistry: an alternative to the NO/O2-reaction. Proc Natl Acad Sci U S A. 2002;99:12691–12696
  54. Comporti M. Introduction-serial review: iron and cellular redox status. Free Radic Biol Med. 2002;32:565–567
  55. Welch KD, Davis TZ, Aust SD. Iron autoxidation and free radical generation: effects of buffers, ligands, and chelators. Arch Biochem Biophys. 2002;397:360–369
  56. Lovstad RA. A kinetic study of the coupled iron-ceruloplasmin catalyzed oxidation of ascorbate in the presence of albumin. Biometals. 1995;8:328–331
  57. Fraga CG, Oteiza PI. Iron toxicity and antioxidant nutrients. Toxicology. 2002;180:23–32
  58. Viner RI, Ferrington DA, Aced GI, Miller-Schlyer M, Bigelow DJ, Schoneich C. In vivo aging of rat skeletal muscle sarcoplasmic reticulum Ca-ATPase (Chemical analysis and quantitative simulation by exposure to low levels of peroxyl radicals). Biochim Biophys Acta. 1997;1329:321–335

 Conflict of interest: none.The financial support for this research was provided by the John S. Dunn, Harold and Leila Mathers, and Robert A. Welch Foundations (AU-1437); National Institute of General Medical Sciences Grant (GM-061731); The Department of Defense (T5 project); as well as The University of Texas and The Shanghai University of TCM. We also acknowledge the support of National Natural Science Foundation (30570710); E-Institutes for Nitric Oxide and Inflammatory Medicine (E-04010) and Key Project (05ZZ11) from Shanghai Municipal Education Commission; Key Project of Shanghai Committee of Science & Technology (05JC14056).

PII: S1933-1711(06)00008-8

doi: 10.1016/j.jash.2006.11.007

Journal of the American Society of Hypertension
Volume 1, Issue 1 , Pages 17-29 , January 2007

Article Tools

* Image Usage & Resolution